ISRT 2026: Advancing Targeted Cancer Treatment Across Africa

Loveworld Medical Centre is strengthening Nigeria’s role in the emerging field of precision oncology through the International Symposium on Radiopharmaceutical Therapy (ISRT) 2026, a major scientific gathering aimed at advancing radiotheranostics, nuclear medicine and molecular imaging across Africa.
The two-day symposium, held on August 28–29, 2026, in Lagos, brought together healthcare professionals, researchers, nuclear medicine specialists, radiopharmacists, oncologists and other experts from across Africa to examine how radiopharmaceutical therapy can transform cancer diagnosis and treatment on the continent.
ISRT 2026 is an official conference of the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) and is organised by Loveworld Medical Centre in collaboration with the International Centers for Precision Oncology (ICPO), the Chris Oyakhilome Foundation International (COFI) and other strategic partners.
The initiative comes amid growing recognition of the need for African countries to expand access to advanced and targeted cancer care. Radiotheranostics, which combines molecular imaging with targeted radionuclide therapy, is increasingly regarded as an important frontier in personalised cancer diagnosis and treatment.
Loveworld Medical Centre has continued to serve as a platform for specialised healthcare, medical education and professional capacity development in Nigeria. Under the leadership of Dr. Deola Phillips, Executive Minister, Ministry of Healing, Health and Social Services and Chairman of Loveworld Medical Centre, the institution has promoted a vision of healthcare built around clinical excellence, innovation, professional development and service to humanity.
Dr. Phillips’ leadership provides an important institutional foundation for the symposium, particularly as African health systems explore new approaches to complex diseases such as cancer. Her role in supporting healthcare development and platforms that bring global medical expertise to Nigeria further highlights Loveworld Medical Centre’s commitment to healthcare transformation across the continent.
Working alongside her, Dr. Emeka Eze, Chief Medical Director of Loveworld Medical Centre and Chairman of ISRT 2026, has provided strategic and professional leadership for the symposium. His efforts have helped bring medical professionals and international stakeholders together around the shared goal of strengthening Africa’s capacity in radiopharmaceutical therapy, nuclear medicine and precision oncology.
Through ISRT 2026, Dr. Eze is helping position Lagos as a centre for scientific exchange and collaboration in a medical field with significant potential to improve cancer outcomes. The symposium offers practitioners an avenue to share knowledge, assess emerging technologies and explore practical ways of integrating advanced theranostic services into African healthcare systems.
WARMTH adds an international dimension to the programme through its focus on radiopharmaceutical and molecular therapy. The association provides a professional platform for knowledge exchange, scientific collaboration and the development of expertise in a rapidly evolving area of medicine.
The International Centers for Precision Oncology (ICPO) contributes expertise in precision medicine and multidisciplinary cancer care, supporting efforts in education, research, clinical practice and international collaboration. Its participation reinforces the symposium’s objective of translating scientific advances into practical approaches to patient care.
The Chris Oyakhilome Foundation International (COFI) complements these efforts through its wider humanitarian focus on health, education and social development. Its involvement underscores the importance of connecting medical advances with improved health outcomes and human wellbeing.
The two-day programme features scientific sessions and practical learning opportunities, including training in radiopharmacy and clinical theragnostics. Discussions cover challenges confronting nuclear medicine in Africa, opportunities in radiopharmaceutical therapy, workforce development, regulatory matters, molecular imaging and the future of precision oncology.
One of the major highlights is the Saul Hertz Best Abstract Award, established in honour of Dr. Saul Hertz, the pioneer of radioiodine therapy and widely recognised as the Father of Theranostics. Sponsored by his daughter, Barbara Hertz, curator of the Dr. Saul Hertz Archives, the award honours outstanding early-career researchers whose work contributes to nuclear medicine, radiopharmaceutical therapy, molecular imaging and precision oncology.
With healthcare professionals from East and West Africa taking part, ISRT 2026 represents a significant effort to strengthen scientific and clinical capacity across the continent while creating opportunities for new collaborations.
For Nigeria, the symposium provides an opportunity to demonstrate the country’s potential to play a leading role in Africa’s emerging precision medicine ecosystem. For Loveworld Medical Centre, it further reinforces its commitment, under the leadership of Dr. Deola Phillips and Dr. Emeka Eze, to healthcare innovation, professional capacity building and access to modern medical solutions.
As cancer remains a major health challenge across Africa, initiatives such as ISRT 2026 are helping shift attention towards earlier diagnosis, targeted treatment, scientific collaboration and a future where precision cancer care is increasingly accessible to patients across the continent.